drugset / Trial / NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
RandomizedSequentialOpen-labelTreatment
Summary
This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).
Timeline
- Start
- 2026-02-19
- Primary completion
- 2029-07-16
- Completion
- 2029-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-1045 | Other / unclassified | — | Intravenous |